Cargando…
Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations
KRIT1 mutations are the most common cause of cerebral cavernous malformation (CCM). Acute Krit1 gene inactivation in mouse brain microvascular endothelial cells (BMECs) changes expression of multiple genes involved in vascular development. These changes include suppression of Thbs1, which encodes th...
Autores principales: | Lopez-Ramirez, Miguel Alejandro, Fonseca, Gregory, Zeineddine, Hussein A., Girard, Romuald, Moore, Thomas, Pham, Angela, Cao, Ying, Shenkar, Robert, de Kreuk, Bart-Jan, Lagarrigue, Frederic, Lawler, Jack, Glass, Christopher K., Awad, Issam A., Ginsberg, Mark H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5679163/ https://www.ncbi.nlm.nih.gov/pubmed/28970240 http://dx.doi.org/10.1084/jem.20171178 |
Ejemplares similares
-
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity
por: Stockton, Rebecca A., et al.
Publicado: (2010) -
Phenotypic Characterization of Murine Models of Cerebral Cavernous Malformations
por: Zeineddine, Hussein A., et al.
Publicado: (2018) -
COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation
por: Shkoukani, Abdallah, et al.
Publicado: (2021) -
Inflammatory Mechanisms in a Neurovascular Disease: Cerebral Cavernous Malformation
por: Li, Ying, et al.
Publicado: (2023) -
Propranolol as therapy for cerebral cavernous malformations: a cautionary note
por: Shenkar, Robert, et al.
Publicado: (2022)